Molecular multitasking in the airspace: α1-antitrypsin takes on thrombin and plasmin

American Journal of Respiratory Cell and Molecular Biology

Volumn 37, Issue 2, 2007, Pages 130-134

  Tuder, Rubin M ^a   Petrache, Irina ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; MACROPHAGE ELASTASE; PLASMIN; PROTEINASE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; EMPHYSEMA; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ENDOTHELIUM; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; INFLAMMATION; LUNG; PLASMIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; THROMBIN;

EID: 34547858953     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0163TR     Document Type: Editorial

References (49)

1. Laurell C-B, Eriksson S. The electrophoretic α1-globulin pattern of α1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:140.
2. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-1102.
3. Snider GL, Kleinerman LJ, Thurlbeck WM, Bengali ZH. The definition of emphysema: report of a National, Heart, Lung and Blood Institute. Division of Lung Diseases Workshop. Am Rev Respir Dis 1985;132: 182-185.
4. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006;7:53.
5. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003;28: 551-554.
6. Henson PM, Cosgrove GP, Vandivier RW. State of the Art. apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:512-516.
7. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006;3:503-510.
8. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet 2005; 2005:2225-2236.
9. Meyer JF, Bieth J, Metais P. On the inhibition of elastase by serum: some distinguishing properties of alpha1-antitrypsin and alpha2-macroglobulin. Clin Chim Acta 1975;62:43-53.
10. Gadek JE, Fells GA, Zimmerman RL, Rennard SI, Crystal RG. Antielastases of the human alveolar structures: implications for the protease-antiprotease theory of emphysema. J Clin Invest 1981;68:889-898.
11. Janciauskiene S, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem Biophys Res Commun 2004;321:592-600.
12. Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C, Martin R, MacKenzie R, Xie C, Zhang L, et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute antiinflammatory effects. Lab Invest 2001;81:1119-1131.
13. Churg A, Wang RD, Xie C, Wright JL. Alpha-1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2003;168:199-207.
14. Moraga F, Janciauskiene S. Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. J Biol Chem 2000;275:7693-7700.
15. Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, Bilton D, Chilvers ER, Lomas DA. Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 2002;26:723-730.
16. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, et al. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006;173:1222-1228.
17. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte T, Tuder RM. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006;169:1155-1166.
18. Song S, Goudy K, Campbell-Thompson M, Wasserfall C, Scott-Jorgensen M, Wang J, Tang Q, Crawford JM, Ellis TM, Atkinson MA, et al. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 2004; 11:181-186.
19. Ruf W. Protease-activated receptor signaling in the regulation of inflammation. Crit Care Med 2004;32:S287-S292.
20. Coughlin SR, Camerer E. PARticipation in inflammation. J Clin Invest 2003;111:25-27.
21. Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation 2006;114:1070-1077.
22. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004;84:579-621.
23. MacNee W, Wiggs B, Belzberg AS, Hogg JC. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 1989; 321:924-928.
24. Dugina TN, Kiseleva EV, Chistov IV, Umarova BA, Strukova SM. Receptors of the PAR family as a link between blood coagulation and inflammation. Biochemistry (Mosc) 2002;67:65-74.
25. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264.
26. Landis RC. Protease activated receptors: clinical relevance to hemostasis and inflammation. Hematol Oncol Clin North Am 2007;21:103-113.
27. Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006;116:1606-1614.
28. Wanner A, Nicod LP, Perruchoud A, Shapiro SD. Purpose of the conference. Proc Am Thorac Soc 2006;3:395.
29. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004;114:997-1008.
30. Major CD, Santulli RJ, Derian CK, Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol 2003;23:931-939.
31. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-2004.
32. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 1999;274:30101-30108.
33. Tuder RM, Voelkel NF. Pathobiology of chronic bronchitis and emphysema. In: Voelkel NF, McNee W, editors. Chronic obstructive lung disease, 1st ed. Montreal: B.C. Decker; 2001.
34. Churg A, Wang RD, Tai H, Wang XS, Xie CS, Dai J, Shapiro SD, Wright JL. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003;167:1083-1089.
35. Churg A, Wang RD, Tai H, Wang XS, Xie CS, Wright JL. Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004;170:492-498.
36. Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005;15:254-259.
37. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 2003;9:338-342.
38. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem 1980;255:3931-3934.
39. Travis J, Beatty K, Wong PS, Matheson NR. Oxidation of alpha 1-proteinase inhibitor as a major, contributing factor in the development of pulmonary emphysema. Bull Eur Physiopathol Respir 1980; 16:341-352.
40. Duranton J, Bieth JG. Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo. Am J Respir Cell Mol Biol 2003;29:57-61.
41. Ogushi F, Hubbard RC, Fells GA, Casolaro MA, Curiel DT, Brantly ML, Crystal RG. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase. Am Rev Respir Dis 1988;137:364-370.
42. Lomas DA, Parfrey H. Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax 2004;59:529-535.
43. Lomas DA, Evans DL, Stone SR, Chang WS, Carrell RW. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry 1993;32:500-508.
44. Hubbard RC, Ogushi F, Fells GA, Cantin AM, Jallat S, Courtney M, Crystal RG. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987;80:1289-1295.
45. Johnson D, Travis J. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem 1979;254:4022-4026.
46. Gans H, Tan BH. Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin. Clin Chim Acta 1967;17:111-117.
47. Vidaud D, Emmerich J, Henc-Gelas M, Yvart J, Fiessinger JN, Aiach M. Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. J Clin Invest 1992;89:1537-1543.
48. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD 2005;2:35-41.
49. 1-Antitrypsin Suppresses TNF-α and MMP-12 Production by Cigarette Smoke-Stimulated Macrophages. Am J Respir Cell Mol Biol 2007;37:144-151.